CN115015533B - 一种氧化低密度脂蛋白测定试剂盒 - Google Patents
一种氧化低密度脂蛋白测定试剂盒 Download PDFInfo
- Publication number
- CN115015533B CN115015533B CN202210607675.7A CN202210607675A CN115015533B CN 115015533 B CN115015533 B CN 115015533B CN 202210607675 A CN202210607675 A CN 202210607675A CN 115015533 B CN115015533 B CN 115015533B
- Authority
- CN
- China
- Prior art keywords
- reagent
- density lipoprotein
- oxidized low
- kit
- alkyl glycoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010071584 oxidized low density lipoprotein Proteins 0.000 title claims abstract description 51
- 238000003149 assay kit Methods 0.000 title claims abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 55
- 229930182470 glycoside Natural products 0.000 claims abstract description 28
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004816 latex Substances 0.000 claims abstract description 13
- 229920000126 latex Polymers 0.000 claims abstract description 13
- 239000004471 Glycine Substances 0.000 claims abstract description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 8
- 239000007983 Tris buffer Substances 0.000 claims abstract description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 8
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001514 detection method Methods 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 150000002338 glycosides Chemical class 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 3
- -1 alkyl glycoside Chemical class 0.000 abstract description 23
- 239000000872 buffer Substances 0.000 abstract description 7
- 239000000243 solution Substances 0.000 abstract description 7
- 230000000087 stabilizing effect Effects 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 8
- 238000012795 verification Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 4
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 4
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 238000004879 turbidimetry Methods 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- 101710095342 Apolipoprotein B Proteins 0.000 description 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
编号 | 下限值(U/mL) | 上限值(U/mL) | R2 |
实施例1 | 0.125 | 35 | 0.9996 |
实施例2 | 0.25 | 35 | 0.9981 |
实施例3 | 0.25 | 35 | 0.9983 |
比较例1 | 0.5 | 35 | 0.9842 |
天数 | 0 | 2 | 4 | 6 | 8 | 10 |
实施例1 | 35.14 | 34.33 | 33.54 | 32.89 | 32.07 | 31.28 |
实施例2 | 35.16 | 34.05 | 33.19 | 31.88 | 30.57 | 29.42 |
实施例3 | 35.22 | 33.72 | 32.45 | 31.08 | 29.79 | 28.36 |
比较例1 | 35.37 | 33.07 | 31.08 | 28.95 | 26.37 | 24.31 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210607675.7A CN115015533B (zh) | 2022-05-31 | 一种氧化低密度脂蛋白测定试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210607675.7A CN115015533B (zh) | 2022-05-31 | 一种氧化低密度脂蛋白测定试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115015533A CN115015533A (zh) | 2022-09-06 |
CN115015533B true CN115015533B (zh) | 2024-06-25 |
Family
ID=
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104181308A (zh) * | 2014-08-22 | 2014-12-03 | 山东博科生物产业有限公司 | 一种稳定的肌钙蛋白i检测试剂 |
CN104597252A (zh) * | 2015-01-23 | 2015-05-06 | 浙江卓运生物科技有限公司 | 一种人血清氧化低密度脂蛋白的免疫比浊检测试剂盒 |
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104181308A (zh) * | 2014-08-22 | 2014-12-03 | 山东博科生物产业有限公司 | 一种稳定的肌钙蛋白i检测试剂 |
CN104597252A (zh) * | 2015-01-23 | 2015-05-06 | 浙江卓运生物科技有限公司 | 一种人血清氧化低密度脂蛋白的免疫比浊检测试剂盒 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101377492B (zh) | 胱抑素c测定试剂盒 | |
CN109596843B (zh) | 一种血清淀粉样蛋白a的测定试剂盒 | |
CN102680698B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) | |
CN108152512A (zh) | 肝素结合蛋白检测试剂盒及其制备方法 | |
CN104215769A (zh) | 一种乳胶增强免疫比浊法ngal检测试剂盒 | |
CN107942069A (zh) | 一种ngal胶乳免疫比浊法检测试剂盒及其制备方法 | |
CN106370860A (zh) | 血清免疫球蛋白e胶体金层析定量检测试剂盒及试纸条 | |
CN102841206B (zh) | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 | |
CN102507918A (zh) | 抗环瓜氨酸肽抗体测定试剂盒 | |
AU3454000A (en) | Method for determining a while blood cell count of a whole blood sample | |
CN111965372B (zh) | 免疫球蛋白e检测试剂盒及其制备方法 | |
CN102128924A (zh) | 乳胶增强免疫比浊法测定尿液转铁蛋白试剂盒及其制备方法 | |
CN106324251A (zh) | 小片段BMG抗体的制备方法及β2‑微球蛋白检测试剂盒 | |
US6087088A (en) | Binding assays using more than one label for determining analyte in the presence of interfering factors | |
CN101046479B (zh) | 不含目标蛋白质人血清基体物质的制备方法 | |
CN115015533B (zh) | 一种氧化低密度脂蛋白测定试剂盒 | |
JP2553852B2 (ja) | サンプル中の生物学的物質の免疫学的測定法 | |
KR20010025027A (ko) | 면역측정시약 및 면역측정법 | |
CN106546729B (zh) | 一种去除干式免疫荧光定量法检测中血清基质效应的新工艺方法 | |
CN114200129B (zh) | 组织金属蛋白酶抑制剂-2胶乳免疫比浊法血尿同检试剂盒 | |
CN115015533A (zh) | 一种氧化低密度脂蛋白测定试剂盒 | |
CN102721819B (zh) | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 | |
GB2217335A (en) | Compositions for isolation and immobilisation of C-reactive protein in body liquids | |
CN110988356A (zh) | C-反应蛋白快速定量免疫层析试纸及其制备方法 | |
JP4524446B2 (ja) | 糖脂質抗原の活性化剤及び活性化方法、並びに試料中の抗糖脂質抗体の測定方法及び測定試薬キット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yi Jianfeng Inventor after: Ma Qingwei Inventor after: Nie Zongxiu Inventor after: Cai Qihao Inventor after: Qian Wei Inventor after: Zeng Yaolong Inventor after: Wang Zhiyi Inventor before: Yi Jianfeng Inventor before: Ma Qingwei Inventor before: Yan Zongxiu Inventor before: Cai Qihao Inventor before: Qian Wei Inventor before: Zeng Yaolong Inventor before: Wang Zhiyi |
|
GR01 | Patent grant |